Director · Whitehawk Therapeutics, Inc. · Whitehawk Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
38.0K
Price
—
Executed
Jun 12, 2026
Disclosed
Jun 15, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jun 12 executedJun 15, 2026 disclosed
WHWK · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Whitehawk Therapeutics, Inc. — Stock Option (right to buy)
Ticker
WHWK
Shares
38.0K
Price per share
$0
Execution date (reported)
Jun 12, 2026
Owned after transaction
38.0K shares
Days from execution to publication
3
What this establishes
Zhao Baiteng filed this Form 4 reporting a grant or award of WHWK on Jun 12, 2026. It became public on Jun 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Zhao Baitengcik:0002049287
Issuer
Whitehawk Therapeutics, Inc.cik:0001422142
Revision history · 0
No field has changed since this record was first ingested.
